Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,131,501 | 1,131,501 | 0 | $29.42M | $45.58M | 23.14% | +$16.16M |
| UroGen Pharma Ltd.(URGN) | 1,259,749 | 1,259,749 | 0 | $17.26M | $25.13M | 12.76% | +$7.87M |
| Puma Biotechnology, Inc.(PBYI) | 4,131,299 | 4,131,299 | 0 | $14.17M | $21.94M | 11.14% | +$7.77M |
| Trevi Therapeutics, Inc.(TRVI) | 2,144,844 | 2,144,844 | 0 | $11.73M | $19.63M | 9.96% | +$7.89M |
| Terns Pharmaceuticals Inc | 1,971,264 | 1,971,264 | 0 | $7.35M | $14.80M | 7.52% | +$7.45M |
| Candel Therapeutics, Inc.(CADL) | 2,580,517 | 2,580,517 | 0 | $13.06M | $13.16M | 6.68% | +$103.2K |
| Bicara Therapeutics | 643,382 | 643,382 | 0 | $5.98M | $10.16M | 5.16% | +$4.18M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 2,839,674 | 2,839,674 | 0 | $6.79M | $7.81M | 3.96% | +$1.02M |
| Protara Therapeutics, Inc.(TARA) | 1,752,115 | 1,752,115 | 0 | $5.31M | $7.62M | 3.87% | +$2.31M |
| Verastem, Inc.(VSTM) | 779,498 | 779,498 | 0 | $3.23M | $6.88M | 3.49% | +$3.65M |
| Cybin D/B/A Helus Pharma(HELP) | 734,394 | 734,394 | 0 | $6.16M | $4.31M | 2.19% | -$1.85M |
| Cardiff Oncology, Inc.(CRDF) | 1,408,767 | 1,962,084 | +553,317 | $4.44M | $4.04M | 2.05% | -$395.7K |
| Aura Biosciences, Inc.(AURA) | 595,744 | 595,744 | 0 | $3.73M | $3.68M | 1.87% | -$47.7K |
| BioAtla, Inc.(BCAB) | 4,835,111 | 4,835,111 | 0 | $1.91M | $3.34M | 1.69% | +$1.42M |
| Jasper Therapeutics, Inc.(JSPR) | 0 | 1,382,640 | +1,382,640 | $0 | $3.29M | 1.67% | +$3.29M |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,139,363 | 1,139,363 | 0 | $2.13M | $2.16M | 1.10% | +$34.2K |
| Q32 Bio Inc.(QTTB) | 803,425 | 803,425 | 0 | $1.20M | $1.59M | 0.81% | +$393.7K |
| X4 Pharmaceuticals, Inc.(XFOR) | 153,730 | 273,349 | +119,619 | $292.1K | $934.9K | 0.47% | +$642.8K |
| Acrivon Therapeutics Inc | 405,237 | 405,237 | 0 | $482.2K | $733.5K | 0.37% | +$251.2K |
| Yarrow Bioscience Inc(YARW) | 736,572 | 586,572 | -150,000 | $1.22M | $199.4K | 0.10% | -$1.02M |
| Mural Oncology Plc | 653,779 | 0 | -653,779 | $1.61M | $0 | — | -$1.61M |
| Y-Mabs Therapeutics Inc | 3,418,995 | 0 | -3,418,995 | $15.42M | $0 | — | -$15.42M |